This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kontoyiannis, D. P.
Right arrow Articles by Rupp, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kontoyiannis, D. P.
Right arrow Articles by Rupp, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2000, p. 1743-1744, Vol. 44, No. 6
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Cyclic AMP and Fluconazole Resistance in Saccharomyces cerevisiae

D. P. Kontoyiannis1,* and Steffen Rupp1,2

Department of Internal Medicine Specialties, Section of Infectious Diseases, The University of Texas M. D. Anderson Cancer Center, Houston, Texas,1 and Fraunhofer IGB, Stuttgart, Germany2

Received 30 November 1999/Returned for modification 2 February 2000/Accepted 11 March 2000

Cyclic AMP (cAMP) is involved in the stress response in Saccharomyces cerevisiae. We show that cAMP is required for resistance to fluconazole in S. cerevisiae. In addition, activation of Ras2, a regulator of cAMP generation, results in some protection from fluconazole toxicity in a fashion independent of the efflux transporter Pdr5p.


* Corresponding author. Mailing address: Department of Internal Medicine Specialties, Section of Infectious Diseases, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 47, Houston, TX 77030. Phone: (713) 792-6237. Fax: (713) 794-4351. E-mail: dkontoyi{at}notes.mdacc.tmc.edu.


Antimicrobial Agents and Chemotherapy, June 2000, p. 1743-1744, Vol. 44, No. 6
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bahn, Y.-S., Molenda, M., Staab, J. F., Lyman, C. A., Gordon, L. J., Sundstrom, P. (2007). Genome-Wide Transcriptional Profiling of the Cyclic AMP-Dependent Signaling Pathway during Morphogenic Transitions of Candida albicans. Eukaryot Cell 6: 2376-2390 [Abstract] [Full Text]  
  • Jain, P., Akula, I., Edlind, T. (2003). Cyclic AMP Signaling Pathway Modulates Susceptibility of Candida Species and Saccharomyces cerevisiae to Antifungal Azoles and Other Sterol Biosynthesis Inhibitors. Antimicrob. Agents Chemother. 47: 3195-3201 [Abstract] [Full Text]